Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients

NCT02825420 · clinicaltrials.gov ↗

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed Ovarian Cancer

Interventions

DRUG: trabectedin

Sponsor

PharmaMar